Explore Our Areas

Latest News

New England Journal of Medicine Publishes Positive Results of Cefepime-Taniborbactam from Phase 3 CERTAIN-1 Study of Patients with Complicated Urinary Tract Infection

Malvern, PA, Parsippany, NJ, and Florence, Italy - February 20, 2024 – Venatorx Pharmaceuticals,  Melinta Therapeutics LLC (“Melinta”), and Menarini Group today...

Venatorx Pharmaceuticals and Menarini Group Enter Commercial Agreement for Cefepime-Taniborbactam in 96 Countries

Malvern, PA, and Florence, Italy, January 9th, 2024  – Venatorx Pharmaceuticals, a private, pre-commercial pharmaceutical company focused on improving health outcomes for...

Menarini Group and Insilico Medicine Enter Global Exclusive License Agreement for Novel KAT6 Inhibitor for Potential Breast Cancer Treatment and Other Oncology Indications

FLORENCE, Italy and NEW YORK, January 4, 2024: The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline...

Search Menarini in the world


Etiam commodo dui eget wisi. Donec iaculis gravida nulla. Donec quis nibh at felis congue commodo. Etiam bibendum elit eget erat.

Use the key combination "ctrl" + "mouse wheel" or the "+" and "-" buttons at the bottom right to browse the map

menarini for people

Discover our responsibility projects to stand close to people

read more

Follow our blog

Discover our stories from all over the world

Read More

fondazione menarini

a meeting point for all friends with common ideals towards the progress of sciences for the benefit of mankind.

Sergio gorini, Foundation’s first President

read more